BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34981432)

  • 1. Newly diagnosed ETV6-RUNX1-positive B-acute lymphoblastic leukemia localized to the left pelvic bone marrow.
    Baba M; Imamura M; Imai C
    Int J Hematol; 2022 Feb; 115(2):151-152. PubMed ID: 34981432
    [No Abstract]   [Full Text] [Related]  

  • 2. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection Exposure Promotes
    Rodríguez-Hernández G; Hauer J; Martín-Lorenzo A; Schäfer D; Bartenhagen C; García-Ramírez I; Auer F; González-Herrero I; Ruiz-Roca L; Gombert M; Okpanyi V; Fischer U; Chen C; Dugas M; Bhatia S; Linka RM; Garcia-Suquia M; Rascón-Trincado MV; Garcia-Sanchez A; Blanco O; García-Cenador MB; García-Criado FJ; Cobaleda C; Alonso-López D; De Las Rivas J; Müschen M; Vicente-Dueñas C; Sánchez-García I; Borkhardt A
    Cancer Res; 2017 Aug; 77(16):4365-4377. PubMed ID: 28630052
    [No Abstract]   [Full Text] [Related]  

  • 6. Discontinuation of L-asparaginase and poor response to prednisolone are associated with poor outcome of ETV6-RUNX1-positive pediatric B-cell precursor acute lymphoblastic leukemia.
    Usami I; Imamura T; Takahashi Y; Suenobu SI; Hasegawa D; Hashii Y; Deguchi T; Hori T; Shimada A; Kato K; Ito E; Moriya-Saito A; Kawasaki H; Hori H; Yumura-Yagi K; Hara J; Sato A; Horibe K;
    Int J Hematol; 2019 Apr; 109(4):477-482. PubMed ID: 30689137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare concomitance of ETV6::RUNX1 and BCR::ABL1p210 in a child diagnosed with B-cell precursor acute lymphoblastic leukemia.
    Barbosa TC; Oliveira E; Blunck CB; Maciel A; Bastos A; Bouzada H; Rouxinol ST; Mansur MB; Costa ES; Almeida CW; Emerenciano M
    Cancer Genet; 2023 Aug; 276-277():40-42. PubMed ID: 37480760
    [No Abstract]   [Full Text] [Related]  

  • 8. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
    Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
    Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.
    Balatzenko G; Guenova M; Kalinova I; Belcheva M; Hristozova H; Kaleva V
    Cancer Genet; 2013 Mar; 206(3):97-101. PubMed ID: 23491079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Landscape of Secondary Genetic Rearrangements in Pediatric Patients with B-Cell Acute Lymphoblastic Leukemia with t(12;21).
    Kaczmarska A; Derebas J; Pinkosz M; Niedźwiecki M; Lejman M
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low Frequency of ETV6-RUNX1 (t 12; 21) in Saudi Arabian Pediatric Acute Lymphoblastic Leukemia Patients: Association with Clinical Parameters and Early Remission.
    Aljamaan K; Aljumah TK; Aloraibi S; Absar M; Iqbal Z
    Asian Pac J Cancer Prev; 2015; 16(17):7523-7. PubMed ID: 26625756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexistence of ETV6/RUNX1 and MLL aberrations in B-cell precursor acute lymphoblastic leukemia discloses a small subclass of BCP-ALL.
    Amare Kadam PS; Raje GC; Pais AP; Banavali S
    Cancer Genet Cytogenet; 2008 Apr; 182(1):27-32. PubMed ID: 18328947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    Yu W; Wang W; Yu X
    PLoS One; 2021; 16(6):e0253012. PubMed ID: 34101758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials.
    Piette C; Suciu S; Clappier E; Bertrand Y; Drunat S; Girard S; Yakouben K; Plat G; Dastugue N; Mazingue F; Grardel N; van Roy N; Uyttebroeck A; Costa V; Minckes O; Sirvent N; Simon P; Lutz P; Ferster A; Pluchart C; Poirée M; Freycon C; Dresse MF; Millot F; Chantrain C; van der Werff Ten Bosch J; Norga K; Gilotay C; Rohrlich PS; Benoit Y; Cavé H
    Leukemia; 2018 Jan; 32(1):244-248. PubMed ID: 29064485
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6-RUNX1: concordant results using quantitation of fusion transcript and flow cytometry.
    Alm SJ; Engvall C; Asp J; Palmqvist L; Abrahamsson J; Fogelstrand L
    Int J Lab Hematol; 2017 Apr; 39(2):121-128. PubMed ID: 28004528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6/RUNX1 induces reactive oxygen species and drives the accumulation of DNA damage in B cells.
    Kantner HP; Warsch W; Delogu A; Bauer E; Esterbauer H; Casanova E; Sexl V; Stoiber D
    Neoplasia; 2013 Nov; 15(11):1292-300. PubMed ID: 24339741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETV6-RUNX1 and RUNX1 directly regulate RAG1 expression: one more step in the understanding of childhood B-cell acute lymphoblastic leukemia leukemogenesis.
    Jakobczyk H; Jiang Y; Debaize L; Soubise B; Avner S; Sérandour AA; Rouger-Gaudichon J; Rio AG; Carroll JS; Raslova H; Gilot D; Liu Z; Demengeot J; Salbert G; Douet-Guilbert N; Corcos L; Galibert MD; Gandemer V; Troadec MB
    Leukemia; 2022 Feb; 36(2):549-554. PubMed ID: 34535762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pinworm infection on the development of murine B-cell leukemia/lymphoma in the presence and absence of
    Fitch BA; Situ J; Wiemels JL; Kogan SC; Zhou M
    Haematologica; 2023 Dec; 108(12):3480-3484. PubMed ID: 37345483
    [No Abstract]   [Full Text] [Related]  

  • 20. RUNX1 aberrations in ETV6/RUNX1-positive and ETV6/RUNX1-negative patients: its hemato-pathological and prognostic significance in a large cohort (619 cases) of ALL.
    Pais AP; Amare Kadam PS; Raje GC; Banavali S; Parikh P; Kurkure P; Arora B; Gujral S; Kumar SA; Badrinath Y
    Pediatr Hematol Oncol; 2008 Sep; 25(6):582-97. PubMed ID: 18728978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.